Advertisement

Topics

Aimmune Therapeutics Presents European Phase 3 PALISADE Screening Data at 2017 European Academy ...

02:06 EDT 20 Jun 2017 | BioMedReports - Blog

Aimmune Therapeutics, Inc.
Investors
Laura Hansen, Ph.D., 650-396-3814
lhansen@aimmune.com
or
Media
Stephanie Yao, 650-351-6479
syao@aimmune.com

Read more...

Original Article: Aimmune Therapeutics Presents European Phase 3 PALISADE Screening Data at 2017 European Academy ...

NEXT ARTICLE

More From BioPortfolio on "Aimmune Therapeutics Presents European Phase 3 PALISADE Screening Data at 2017 European Academy ..."

Advertisement
Quick Search
Advertisement
Advertisement